Submitted Clinical Trials
Below is an overview of our current and upcoming clinical programs. All trials are conducted under institutional review and regulatory oversight, in collaboration with licensed hospitals and our cGMP manufacturing partner Vivosel.
Trial status and availability are subject to change. For eligibility inquiries, please complete our Pre-Consultation Screening.
MSC & Exosome Therapy for Knee Osteoarthritis
Evaluating the safety and efficacy of autologous and allogeneic MSC injections combined with MSC-derived exosomes for moderate-to-severe knee osteoarthritis in adult patients.
CAR-T CD19 Cell Therapy for B-Cell Leukemia
A safety and efficacy study of CAR-T CD19 cell therapy for patients with relapsed or refractory B-cell acute lymphoblastic leukemia, conducted under institutional review and regulatory oversight.
The information on this page is provided for general informational purposes only and does not constitute medical advice. Clinical trial participation is subject to eligibility criteria, regulatory approval, and physician assessment. Age Back Co. does not guarantee enrollment or outcomes.